Navigation Links
Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Date:9/26/2007

ual sales of approximately $800 million in the US alone."

About Gentamicin Surgical Implant

GENTAMICIN SURGICAL IMPLANT is a fully biodegradable, leave-behind surgical implant impregnated with the broad spectrum aminoglycoside antibiotic, gentamicin. It was developed using Innocoll's proprietary collagen-based technology, CollaRx(R), and is designed to provide a high concentration of gentamicin (which has a concentration-dependent mechanism of action) at the target tissue while maintaining low systemic levels well below the toxicity threshold. The product is indicated as an adjunct to systemic antibiotic therapy for the prevention of surgical site infections and for the treatment of deep, localized infections in both hard and soft tissues. There are more than 60 prospective clinical trials and published case reports totalling over 7,500 patients documenting safety and efficacy over a broad range of orthopaedic, colorectal, cardiothoracic, vascular, and neurosurgical procedures. The product is already approved in 49 countries spanning Europe, Latin America, Middle East, Africa and Asia and is marketed by EUSA Pharma under the following trade names; COLLATAMP(R) G, COLLATAMP(R) EG, SULMYCIN(R) IMPLANT, GARAMYCIN(R) SCHWAMM, DURACOL(R), DURACOLL(R), GENTACOL(R), GENTACOLL(R), GARACOL(R), GARACOLL(R) and CRONOCOL(R).

GENTAMICIN SURGICAL IMPLANT is under development in the US for the prevention of surgical site infections. An IND has been approved by the FDA and Innocoll plans to conduct two US multi-centered phase 3 clinical trials; one in cardiac surgery patients at higher risk of surgical site infection and the other in patients undergoing open colorectal surgery. Innocoll has appointed Duke University's Duke Clinical Research Institute (DCRI) as the Study Co-ordinating Center for both trials. Independent market research recently performed by L.E.K. Consulting projected peak US sales of greater than US$200 million per annum.

About CollaRx(R) Ge
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. XTL Provides Update on Phase I Clinical Trial of XTL-2125
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
6. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
7. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
8. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
9. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
10. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
11. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Greenway Medical Technologies, ... EHR, Prime Suite (®) 2011, ... Ambulatory EHR, additionally certified for Child Health ... Greenway,s Prime Suite 2011 achieved the ... designations offered by the Certification Commission for ...
(Date:12/14/2009)... 14 Environmental health advocates hope that ... health hazards of bisphenol A (BPA), a synthetic ... harm and other illnesses, in time for Christmas. ... , staff scientist, Natural Resources Defense Council ... for medical advice, FDA must rely on the ...
(Date:12/14/2009)... 14 At GeoInvesting.com, we have been tracking ... time now. Our largest hang up had been with ... fiscal June 2010 net income guidance of $11.3 million ... net income of $7.9 million, the increase in shares ... scenario, which depends upon the share price and the ...
Breaking Medicine Technology:Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 1NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 3Triage Wireless Inc Becomes Sotera Wireless Inc 6282 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 2
... 8 IntelligentMDx a developer and manufacturer of proprietary ... of the IntelligentMDx BK Viral Quantitative Assay are ... Detection, linearity, specificity and reproducibility and robustness of ... data obtain agreed with internally generated analytical performance ...
... Infants Drive the IncreaseWHITE PLAINS, N.Y., Jan. 7 ... the United States preterm birth rate continues, putting more ... disability according to the March of Dimes.Nearly 543,000 babies ... National Center for Health Statistics, which today released "Births: ...
Other Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Preterm Births Rise 36 Percent Since Early 1980s 2
(Date:12/14/2009)... Twelve variants seen in one gene, researchers say , , ... pinpointed a dozen genetic variants in a single gene ... University School of Medicine in St. Louis analyzed the ... heart failure, and identified 129 variants in four genes ... of 1,117 whites with heart failure and 625 healthy ...
(Date:12/14/2009)... government controlled health care, before moving to the U.S. to practice ... his new book, Health Reform: The End of the American Revolution?, ... its threat to real health care! , ... (PRWEB) ... from Minnesota, warns Americans not to sell out their liberty for ...
(Date:12/14/2009)... CT procedures vary widely and are higher than generally thought, raising ... led by University of California, San Francisco (UCSF) imaging ... ... 2009 -- Radiation doses from common CT procedures vary widely and ... cancer, according to a new study led by University of ...
(Date:12/14/2009)... Pasierb, President ,, NEW YORK, Dec. 14 ... the Future study (MTF) -- the largest survey on ... 12th graders -- underscores that teens, intentional abuse of ... a cause for concern, with an alarming number of ... relatives. ,, Teen Abuse of Medication ...
(Date:12/14/2009)... 14 Grubb & Ellis Healthcare REIT II, Inc. ... daily distribution to stockholders of record as of the close ... Jan. 1, 2010 and ending on Feb. 28, 2010. ... the calendar year and will be equal to an annualized ... $10.00 per share. These distributions will be aggregated and ...
Breaking Medicine News(10 mins):Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3
... the number of people with vision loss from age-related macular ... is caused by a deterioration of the retina, is the ... of years ago, researchers conducted a large study to see ... beta carotene, along with zinc oxide or zinc alone could ...
... symptoms women experience before having a heart attack may ... experience. ,Researchers interviewed more than 500 women who ... different medical sites. The average age of the women ... their symptoms before their heart attack. They also took ...
... premature birth are a mystery in nearly half of the ... stress, infections, high blood pressure, //bleeding or stretching of the ... experts say fertility troubles could explain part of the problem. ... 37 weeks of pregnancy -- is a major public health ...
... viral cold are common in preschoolers. These attacks are ... school age. //The current recommendation is that parents administer ... But whether or not the steroids are effective is ... steroids was no more effective than placebo in reducing ...
... a major improvement for HIV patients in less-developed countries. The ... HIV medication.// ,HIV patients are often put on antiretroviral ... on the medication, tests to determine the CD4 cell count ... for more intensive treatment while a high CD4 cell count ...
... have a new tool to help acne patients. A new ... sufferers. //This is important because this skin disease can lead ... even suicide. ,Doctors from London recruited 41 adults with ... one treatment of the pulsed-dye laser. The other 10 served ...
Other Medicine News:Health News:Women who conceive after a year have a higher chance of giving birth prematurely 2
Spectrum Dynamics empowers Nuclear Imaging with the SmartR Technology,of the D-SPECT Cardiac Imaging System. The D-SPECT is powered by BroadView Technology to provide unprecedented throughput, whil...
For immediate disabling...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
... A valuable new tool for the ... greater dynamic range and shows less ... at the same degree of reproducibility ... been shown to correlate with the ...
Medicine Products: